| Target Price consensus revisions : last 18 months |
|
|
|
| Evolution of the average Target Price on ROCHE HOLDING AG |
|
|
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
|
Roche buys GenMark for $1.8 million to challenge test rivals |
| Mean consensus |
OUTPERFORM |
| Number of Analysts |
26 |
| Average target price |
355,40 CHF |
| Last Close Price |
348,25 CHF |
| Spread / Highest target |
25,8% |
| Spread / Average Target |
2,05% |
| Spread / Lowest Target |
-16,7% |
Consensus revision (last 18 months)
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
